| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5944828 | Atherosclerosis | 2014 | 9 Pages |
Abstract
Based on these results, we suggest that in addition to the well known mimetic peptides, other suitable cationic peptides may be of use for controlling Ox-LDL mediated inflammation and atherosclerotic progression.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chandrakala Aluganti Narasimhulu, Krithika Selvarajan, Matthew Brown, Sampath Parthasarathy,